Thermo Fisher Scientific Inc. (BMV:TMO)
9,745.73
-201.25 (-2.02%)
At close: Oct 10, 2025
Thermo Fisher Scientific Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 4,576 | 4,009 | 8,077 | 8,524 | 4,477 | 10,325 | Upgrade |
Short-Term Investments | 1,814 | 1,561 | 3 | - | - | - | Upgrade |
Cash & Short-Term Investments | 6,390 | 5,570 | 8,080 | 8,524 | 4,477 | 10,325 | Upgrade |
Cash Growth | -27.58% | -31.06% | -5.21% | 90.40% | -56.64% | 330.39% | Upgrade |
Accounts Receivable | 8,594 | 8,191 | 8,221 | 8,115 | 7,977 | 5,741 | Upgrade |
Inventory | 5,559 | 4,978 | 5,088 | 5,634 | 5,051 | 4,029 | Upgrade |
Other Current Assets | 4,040 | 3,399 | 3,200 | 2,956 | 2,608 | 1,862 | Upgrade |
Total Current Assets | 24,584 | 22,137 | 24,589 | 25,229 | 20,113 | 21,957 | Upgrade |
Net Property, Plant & Equipment | 9,635 | 9,306 | 9,448 | 9,280 | 8,333 | 5,912 | Upgrade |
Other Intangible Assets | 15,148 | 15,533 | 16,670 | 17,442 | 20,113 | 12,685 | Upgrade |
Goodwill | 47,249 | 45,853 | 44,020 | 41,196 | 41,924 | 26,041 | Upgrade |
Other Long-Term Assets | 4,615 | 4,492 | 3,999 | 4,007 | 4,640 | 2,457 | Upgrade |
Total Assets | 101,230 | 97,321 | 98,726 | 97,154 | 95,123 | 69,052 | Upgrade |
Accounts Payable | 2,980 | 3,079 | 2,872 | 3,381 | 2,867 | 2,175 | Upgrade |
Accrued Expenses | 4,718 | 5,187 | 4,842 | 5,449 | 5,377 | 4,230 | Upgrade |
Short-Term Debt | 2,214 | 2,214 | 3,609 | 5,579 | 2,537 | 2,628 | Upgrade |
Unearned Revenue | 2,805 | 2,852 | 2,689 | 2,601 | 2,655 | 1,271 | Upgrade |
Total Current Liabilities | 12,718 | 13,332 | 14,012 | 17,010 | 13,436 | 10,304 | Upgrade |
Long-Term Debt | 33,015 | 29,061 | 31,308 | 28,909 | 32,333 | 19,107 | Upgrade |
Other Long-Term Liabilities | 4,894 | 5,257 | 6,564 | 7,087 | 8,377 | 5,124 | Upgrade |
Total Long-Term Liabilities | 37,909 | 34,318 | 37,872 | 35,996 | 40,710 | 24,231 | Upgrade |
Total Liabilities | 50,627 | 47,650 | 51,884 | 53,006 | 54,146 | 34,535 | Upgrade |
Common Stock | 444 | 444 | 442 | 441 | 439 | 437 | Upgrade |
Treasury Stock | -21,269 | -19,226 | -15,133 | -12,017 | -8,922 | -6,818 | Upgrade |
Additional Paid-in Capital | 18,232 | 17,962 | 17,286 | 16,743 | 16,174 | 15,579 | Upgrade |
Accumulated Other Comprehensive Income | -2,797 | -2,697 | -3,224 | -3,099 | -2,329 | -2,807 | Upgrade |
Retained Earnings | 55,901 | 53,102 | 47,364 | 41,910 | 35,431 | 28,116 | Upgrade |
Total Common Shareholders' Equity | 50,512 | 49,584 | 46,735 | 43,978 | 40,793 | 34,507 | Upgrade |
Minority Interest | 91 | 87 | 107 | 170 | 184 | 10 | Upgrade |
Shareholders' Equity | 50,602 | 49,671 | 46,842 | 44,148 | 40,977 | 34,517 | Upgrade |
Total Liabilities & Equity | 101,230 | 97,321 | 98,726 | 97,154 | 95,123 | 69,052 | Upgrade |
Total Debt | 35,229 | 31,275 | 34,917 | 34,488 | 34,870 | 21,735 | Upgrade |
Net Cash (Debt) | -28,839 | -25,705 | -26,837 | -25,964 | -30,393 | -11,410 | Upgrade |
Net Cash Per Share | -75.79 | -67.11 | -69.17 | -65.90 | -76.56 | -28.60 | Upgrade |
Book Value | 50,512 | 49,584 | 46,735 | 43,978 | 40,793 | 34,507 | Upgrade |
Book Value Per Share | 132.75 | 129.46 | 120.45 | 111.62 | 102.75 | 86.48 | Upgrade |
Tangible Book Value | -11,885 | -11,802 | -13,955 | -14,660 | -21,244 | -4,219 | Upgrade |
Tangible Book Value Per Share | -31.24 | -30.81 | -35.97 | -37.21 | -53.51 | -10.57 | Upgrade |
Updated Jun 28, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.